Wein Matthew 4
4 · Metagenomi Therapeutics, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Metagenomi (MGX) General Counsel Matthew Wein Sells 482 Shares
What Happened
Matthew Wein, Metagenomi's General Counsel, Compliance Officer and Corporate Secretary, had 482 shares of common stock sold on 2026-03-05 at $1.60 per share for proceeds reported as $771. The sale was recorded as an S (sale) transaction but, per the filing footnote, was an automatic sale to satisfy tax withholding on vested restricted stock units and not a volitional trade.
Key Details
- Transaction date: 2026-03-05; Price: $1.60 per share; Shares sold: 482; Proceeds reported: $771.
- Transaction type/code: Sale (S); Footnote (F1) indicates sale was automatic to cover tax withholding on RSU vesting.
- Shares owned after transaction: Not specified in the provided excerpt—see the full Form 4 for total beneficial ownership.
- Filing date: 2026-03-09. Filed within the standard two-business-day Form 4 deadline for a 2026-03-05 transaction.
Context
Automatic sell-to-cover transactions for tax withholding are routine when restricted stock units vest and do not necessarily indicate insider sentiment about the company. This was a small, routine withholding sale rather than a discretionary sale; purchases (when reported) are generally more informative about insider confidence.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-05$1.60/sh−482$771→ 114,549 total
Footnotes (1)
- [F1]These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.